Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin G Duffy

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Nature Reviews. Gastroenterology & Hepatology|February 9, 2017
Liver cancer: Regorafenib as second-line therapy in hepatocellular carcinomaAustin G Duffy, Tim F Greten
Hepatic Oncology|September 8, 2018
Hepatocellular carcinoma and immune therapy, from a clinical perspective; where are we?Susanna V Ulahannan, Austin G Duffy
Chinese Clinical Oncology|September 11, 2023
Brave new world-new and emerging treatments for gastric cancerEmer Lynch, Austin G Duffy, Ronan J Kelly
Seminars in Liver Disease|March 9, 2022
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?Hailey K Carroll, Austin G Duffy, Cliona O'Farrelly
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
Hepatocellular carcinoma from an immunologic perspectiveTim F Greten, Austin G Duffy, Firouzeh Korangy
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric AdenocarcinomaEmer Lynch, Austin G Duffy, Ronan J Kelly
Cancers|November 25, 2023
Role of Immunotherapy in Gastroesophageal Cancers-Advances, Challenges and Future StrategiesEmer Lynch, Austin G Duffy, Ronan J Kelly
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Emerging RAS-directed therapies for cancerMichael Conroy, Darren Cowzer, Walter Kolch, et al.
Hepatology (Baltimore, Md.)|May 15, 2016
The case for immune-based approaches in biliary tract carcinomaAustin G Duffy, Oxana V Makarova-Rusher, Tim F Greten
JAMA Oncology|July 17, 2015
Colorectal Cancer Survival Gains and Novel Treatment Regimens: A Systematic Review and AnalysisIrfan Jawed, Julia Wilkerson, Vinay Prasad, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Nature Reviews. Gastroenterology & Hepatology|February 9, 2017
Liver cancer: Regorafenib as second-line therapy in hepatocellular carcinomaAustin G Duffy, Tim F Greten
Hepatic Oncology|September 8, 2018
Hepatocellular carcinoma and immune therapy, from a clinical perspective; where are we?Susanna V Ulahannan, Austin G Duffy
Chinese Clinical Oncology|September 11, 2023
Brave new world-new and emerging treatments for gastric cancerEmer Lynch, Austin G Duffy, Ronan J Kelly
Seminars in Liver Disease|March 9, 2022
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?Hailey K Carroll, Austin G Duffy, Cliona O'Farrelly
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
Hepatocellular carcinoma from an immunologic perspectiveTim F Greten, Austin G Duffy, Firouzeh Korangy
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric AdenocarcinomaEmer Lynch, Austin G Duffy, Ronan J Kelly
Cancers|November 25, 2023
Role of Immunotherapy in Gastroesophageal Cancers-Advances, Challenges and Future StrategiesEmer Lynch, Austin G Duffy, Ronan J Kelly
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Emerging RAS-directed therapies for cancerMichael Conroy, Darren Cowzer, Walter Kolch, et al.
Hepatology (Baltimore, Md.)|May 15, 2016
The case for immune-based approaches in biliary tract carcinomaAustin G Duffy, Oxana V Makarova-Rusher, Tim F Greten
JAMA Oncology|July 17, 2015
Colorectal Cancer Survival Gains and Novel Treatment Regimens: A Systematic Review and AnalysisIrfan Jawed, Julia Wilkerson, Vinay Prasad, et al.
Pageof 4